Last NEWS
I2MC
Starlab seminar : towards a more sustainable laboratory
On Tuesday May 23 at 11 a.m. in the Hérvé Paris room, the Starlab company will offer a seminar on its green actions and its new recycling method. Flyer présentation Green I2MC 23-05-2023
The scientific retreat of I2MC is coming
Les 5 et 6 juin 2023 aura lieu la retraite scientifique de l'I2MC au Mas de Saboth à St Géry Vers dans le Lot. Au programme : des ateliers / tables rondes sur des thématiques variées, des sessions posters, des temps de cohésion et de convivialité et surtout un maximum...
External Seminar
Vendredi 12 Mai à 11h, I2MC Salle H. Paris, le Pr. Damien Freyssenet - Laboratoire Interuniversitaire de Biologie de la Motricité EA 7424, Université Jean Monnet Saint-Etienne, Saint-Priest-en-Jarez, France - donnera un séminaire intitulé “A systemic approach of...
LiMitAging team’s work in La Dépêche
Un article de la Dépêche du Midi évoque les travaux de l'équipe LiMitAging menés par Souad Najib sur les bénéfices cardiovasculaires du jeûne intermittent. Cet article fait référence à la récente parution des résultats de cette étude dans la revue Cells :...
New review from MetaDiab (C. Moro) team in Biochimie
Does housing temperature influence glucose regulation and muscle-fat crosstalk in mice? Auteurs : Marlène Lac, Geneviève Tavernier, Cedric Moro Abstract The robustness of scientific results is partly based on their reproducibility. Working with animal models,...
The I2MC is looking for a new group leader
Group Leader Position at the Institute of Metabolic & Cardiovascular Disease Job description The Institute of Metabolic and Cardiovascular Diseases (I2MC, Inserm, University of Toulouse, www.i2mc.inserm.fr/en) is looking for a young scientist or an established...
EndoTreat: research project conducted in partnership with the Toulouse University Hospital (E. Chantalat), INSERM-I2MC (F. Lenfant) and the start-up company Urosphère
Endometriosis: researchers in Toulouse study the disease by creating organoids (Equipe de Françoise LENFANT) Click here to read article in the Dépêche. To better understand the mechanisms of endometriosis, an oestrogen-dependent disease that affects 10% of women in...
We-Met involved in Europen project HERVCOV
The protein that opens doors to the medicine of the future and treatment of COVID-19 “Understand the pathogenic role of HERV-W envelope protein and develop novel prognostic markers and therapeutic targets for personalized treatment of COVID-19-associated...
Discovery and quantification of lipoamino acids in bacteria – Lipidomic facility
Improving knowledge about metabolites produced by the microbiota is a key point to understand its role in human health and disease. Among them, lipoamino acid (LpAA) containing asparagine and their derivatives are bacterial metabolites which could have an impact on...
A new mass spectrometer high resolution on Metatoul-Lipidomic facility: EXPLORIS 240
Thanks to CPER and regional funding (Occitanie Octopus project), the MetaToul-Lipidomic platform has acquired a chromatography instrument coupled to a high-resolution mass spectrometer of the Exporis 240 (Thermo). This instrument, which replaces our simple Exactive,...
Inserm/UPS UMR 1297 - I2MC Institut des Maladies Métaboliques et Cardiovasculaires
1 avenue Jean Poulhès - BP 84225 - 31432 Toulouse Cedex 4
Tél. : 05 61 32 56 00
Horaires
Du lundi au vendredi
8h30 - 12h30 / 13h45 -16h45
